ANEB
Anebulo Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$0.50
-0.32 (-39.05%)
Open$0.44
Previous Close$0.82
Day High$0.66
Day Low$0.44
52W High$42.41
52W Low$30.02
Volume—
Avg Volume753.7K
Market Cap20.56M
P/E Ratio21.90
EPS$1.74
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+9,888.0% upside
Current
$0.50
$0.50
Target
$49.99
$49.99
$34.23
$49.99 avg
$60.95
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.41M | 5.09M | 4.82M |
| Net Income | 1.02M | 757.9K | 675.0K |
| Profit Margin | 18.8% | 14.9% | 14.0% |
| EBITDA | 1.84M | 1.51M | 1.49M |
| Free Cash Flow | 747.3K | 835.9K | 744.4K |
| Rev Growth | +9.4% | +17.9% | +10.5% |
| Debt/Equity | 0.83 | 0.81 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |